Biotech

CN Bio Expands ADME Services with Computational Modeling Tools to Advance Drug Discovery

CN Bio has launched new PhysioMimix® computational modeling tools to strengthen ADME profiling, improve bioavailability predictions, and accelerate drug discovery workflows.

Domainex and Pharmacelera Partner to Advance AI-Driven Drug Discovery for Transmembrane Proteins

Collaboration integrates quantum mechanics-based modelling with cutting-edge experimental platforms to accelerate hit discovery for GPCRs and ion channels.

Qureight AI to Power Calluna’s Phase 2 IPF Study

AI-powered 3D lung imaging to accelerate assessment of CAL101, a first-in-class antibody targeting a key driver of fibrosis.

International Team to Build First Fully Synthetic Chloroplast Genomes

Camena Bioscience and Constructive Bio are partnering with global researchers to create the first fully synthetic chloroplast genomes.

Atelerix Appoints Industry Heavyweights to Board as It Gears Up for Global Expansion

Atelerix has appointed biotech leaders Sunil Shah and Dr Catherine Elton to its Board to support the company’s global commercial expansion and scale-up of its innovative cell preservation technology.

Allogene Pivoting Lymphodepletion Strategy in ALPHA3 CAR‑T Trial Following Patient Death

Allogene Therapeutics has revised its ALPHA3 CAR T trial to use only standard lymphodepletion after a patient death linked to its investigational antibody.